Hg, a private equity firm, agreed to invest $27m in Managed Markets Insight & Technology, a provider of formulary tools and solutions. "MMIT and Evaluate share a mission of helping patients get access to lifesaving therapies. As customers' decision-making processes become increasingly more centralized, we couldn't be more thrilled to come together and offer a comprehensive solution for bringing new drugs to market and to patients," Mike Gallup, MMIT CEO.